Aspirin for Preventing the Recurrence of Venous Thromboembolism
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
BACKGROUND: About 20% of patients with unprovoked venous thromboembolism have a recurrence within 2 years after the withdrawal of oral anticoagulant therapy. Extending anticoagulation prevents recurrences but is associated with increased bleeding. The benefit of aspirin for the prevention of recurrent venous thromboembolism is unknown. METHODS: In this multicenter, investigator-initiated, double-blind study, patients with first-ever unprovoked venous thromboembolism who had completed 6 to 18 months of oral anticoagulant treatment were randomly assigned to aspirin, 100 mg daily, or placebo for 2 years, with the option of extending the study treatment. The primary efficacy outcome was recurrence of venous thromboembolism, and major bleeding was the primary safety outcome. RESULTS: Venous thromboembolism recurred in 28 of the 205 patients who received aspirin and in 43 of the 197 patients who received placebo (6.6% vs. 11.2% per year; hazard ratio, 0.58; 95% confidence interval [CI], 0.36 to 0.93) (median study period, 24.6 months). During a median treatment period of 23.9 months, 23 patients taking aspirin and 39 taking placebo had a recurrence (5.9% vs. 11.0% per year; hazard ratio, 0.55; 95% CI, 0.33 to 0.92). One patient in each treatment group had a major bleeding episode. Adverse events were similar in the two groups. CONCLUSIONS: Aspirin reduced the risk of recurrence when given to patients with unprovoked venous thromboembolism who had discontinued anticoagulant treatment, with no apparent increase in the risk of major bleeding. (Funded by the University of Perugia and others; WARFASA ClinicalTrials.gov number, NCT00222677.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The WARFASA 309 and ASPIRE 318 trials compared aspirin, 100 mg daily, with placebo for secondary prevention of recurrent VTE for patients with an initial unprovoked event, and the pooled results of the 2 trials showed a decrease in recurrent VTE, as well as major vascular events, without an increased risk for clinically relevant bleeding. 309,315”
From American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism (2020) · cites this paper as [309]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Consequently, several studies have investigated the role of aspirin for the secondary prevention of VTE. 309,314,315”
From American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism (2020) · cites this paper as [309]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oral Rivaroxaban for Symptomatic Venous Thromboembolism
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1007903 · Cited by 3,237
The Long-Term Clinical Course of Acute Deep Venous Thrombosis
Prandoni, P., Lensing, A. W. A., Cogo, A., Cuppini, S., Villalta, S., Carta, M., Cattelan, A. M., Polistena, P., Bernardi, E., & Prins, M. H. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-1-199607010-00001 · Cited by 2,109
Self-citationAntithrombotic Therapy for Venous Thromboembolic Disease
Hyers, T. M., Agnelli, G., Hull, R. D., Morris, T. A., Samama, M., Tapson, V., & Weg, J. G. (2001) · Chest · doi:10.1378/chest.119.1_suppl.176s · Cited by 2,042
Self-citationAntithrombotic Therapy for Venous Thromboembolic Disease
Kearon, C., Kahn, S. R., Agnelli, G., Goldhaber, S., Raskob, G. E., & Comerota, A. J. (2008) · Chest · doi:10.1378/chest.08-0658 · Cited by 1,996
Self-citation(2000) · The Lancet · doi:10.1016/s0140-6736(00)02110-3 · Cited by 1,076
Kearon, C., Gent, M., Hirsh, J., Weitz, J., Kovacs, M. J., Anderson, D. R., Turpie, A. G., Green, D., Ginsberg, J. S., Wells, P., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903253401201 · Cited by 1,072
del Conde, I., Shrimpton, C. N., Thiagarajan, P., & López, J. A. (2005) · Blood · doi:10.1182/blood-2004-03-1095 · Cited by 1,029
Schulman, S., Rhedin, A.-S., Lindmarker, P., Carlsson, A., Lärfars, G., Nicol, P., Loogna, E., Svensson, E., Ljungberg, B., Walter, H., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506223322501 · Cited by 932
Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous Thromboembolism
Ridker, P. M., Goldhaber, S. Z., Danielson, E., Rosenberg, Y., Eby, C. S., Deitcher, S. R., Cushman, M., Moll, S., Kessler, C. M., Elliott, C. G., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035029 · Cited by 808
Linkins, L.-A., Choi, P. T., & Douketis, J. D. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-11-200312020-00007 · Cited by 764
Research works printed but not linked: 2
- Schulman S, 2011, J Thromb Haemost, 9, 731
- Schulman S, 2011, J Thromb Haemost, 9, 22
Cited by
Items 101–200 of 630
Association of platelet activation markers with cancer-associated venous thromboembolism
Riedl, J., Hell, L., Kaider, A., Koder, S., Marosi, C., Zielinski, C. C., Panzer, S., Pabinger, I., & Ay, C. (2015) · Platelets · doi:10.3109/09537104.2015.1041901 · Cited by 56
McCormack, T., Harrisingh, M. C., Horner, D. E., & Bewley, S. (2020) · BMJ · doi:10.1136/bmj.m1565 · Cited by 59
Marik, P. E., & Cavallazzi, R. (2015) · PLOS ONE · doi:10.1371/journal.pone.0143252 · Cited by 53
Bauersachs, R. M., Beyer‐Westendorf, J., Bounameaux, H., Brighton, T., Cohen, A. T., Davidson, B. L., Holberg, G., Kakkar, A. K., Lensing, A. W. A., Prins, M. H., et al. (2015) · Thrombosis and Haemostasis · doi:10.1160/th15-02-0131 · Cited by 55
Self-citationHeit, J. A., Lahr, B. D., Ashrani, A. A., Petterson, T. M., & Bailey, K. R. (2015) · Thrombosis Research · doi:10.1016/j.thromres.2015.06.030 · Cited by 58
Aspirin for prevention and treatment of venous thromboembolism
Becattini, C., & Agnelli, G. (2014) · Blood Reviews · doi:10.1016/j.blre.2014.03.003 · Cited by 53
Self-citationStatin treatment and risk of recurrent venous thromboembolism: a nationwide cohort study
Nguyen, C. D., Andersson, C., Jensen, T. B., Gjesing, A., Olsen, A. S., Hansen, C. M., Buller, H. R., Torp-Pedersen, C. T., & Gislason, G. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-003135 · Cited by 53
Current knowledge on the genetics of incident venous thrombosis
Morange, P., & Trégouët, D. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12233 · Cited by 68
Mirrakhimov, A. E., Ali, A. M., Barbaryan, A., Prueksaritanond, S., & Hussain, N. (2014) · International Journal of Nephrology · doi:10.1155/2014/916760 · Cited by 52
Impact of Incident Venous Thromboembolism on Risk of Arterial Thrombotic Diseases
Lind, C., Flinterman, L. E., Enga, K. F., Severinsen, M. T., Kristensen, S. R., Brækkan, S. K., Mathiesen, E. B., Njølstad, I., Cannegieter, S. C., Overvad, K., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.004168 · Cited by 59
Sardar, P., Chatterjee, S., & Mukherjee, D. (2013) · Drugs · doi:10.1007/s40265-013-0082-7 · Cited by 50
Does aspirin prevent venous thromboembolism?
Diep, R. T., & Garcia, D. A. (2020) · Hematology · doi:10.1182/hematology.2020000150 · Cited by 50
Management of venous thromboembolism: an update
Piran, S., & Schulman, S. (2016) · Thrombosis Journal · doi:10.1186/s12959-016-0107-z · Cited by 53
Effects of aspirin and enoxaparin in a rat model of liver fibrosis
Li, C.-J., Yang, Z., Shi, X., & Liu, D. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i35.6412 · Cited by 47
Ren, L., Pan, S., Li, H., Li, Y., He, L., Zhang, S., Che, J., & Niu, Y. (2018) · Scientific Reports · doi:10.1038/s41598-018-33353-7 · Cited by 47
Arterial and venous thrombosis: What's the link? A narrative review
Delluc, A., Lacut, K., & Rodger, M. A. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.04.035 · Cited by 47
Poujol‐Robert, A., Boëlle, P., Conti, F., Durand, F., Duvoux, C., Wendum, D., Paradis, V., Mackiewicz, V., Chazouillères, O., Corpechot, C., et al. (2014) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2014.07.004 · Cited by 47
Historical Lessons in Translational Medicine: Cyclooxygenase Inhibition and P2Y12 Antagonism
Fitzgerald, D. J., & FitzGerald, G. A. (2013) · Circulation Research · doi:10.1161/circresaha.111.300271 · Cited by 53
Hormone replacement therapy and venous thromboembolism
Eisenberger, A. B., & Westhoff, C. L. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.08.016 · Cited by 50
Recurrent Venous Thromboembolism: What Is the Risk and How to Prevent It
Palareti, G. (2012) · Scientifica · doi:10.6064/2012/391734 · Cited by 47
Stewart, L. K., & Kline, J. A. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019000561 · Cited by 45
Managing pulmonary embolism from presentation to extended treatment
Cohen, A. T., Dobromirski, M., & Gurwith, M. M. P. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2013.09.040 · Cited by 49
Skeith, L., Carrier, M., Robinson, S. E., Alimam, S., & Rodger, M. A. (2017) · Blood · doi:10.1182/blood-2016-09-728006 · Cited by 47
Bleker, S. M., van Es, N., van Gils, L., Daams, J. G., Kleinjan, A., Buller, H. R., & Nisio, M. D. (2016) · Thrombosis Research · doi:10.1016/s0049-3848(16)30104-9 · Cited by 45
Sobieraj, D. M., Coleman, C. I., Pasupuleti, V., Deshpande, A., Kaw, R., & Hernandez, A. V. (2015) · Thrombosis Research · doi:10.1016/j.thromres.2015.02.032 · Cited by 42
Platelets in Pulmonary Vascular Physiology and Pathology
Kroll, M. H., & Afshar‐Kharghan, V. (2012) · Pulmonary Circulation · doi:10.4103/2045-8932.101398 · Cited by 52
Wu, C. M., Alotaibi, G., AlSaleh, K. A., Linkins, L., & McMurtry, M. S. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.10.033 · Cited by 43
Aspirin in the Prevention of Cardiovascular Disease and Cancer
Ricciotti, E., & FitzGerald, G. A. (2021) · Annual Review of Medicine · doi:10.1146/annurev-med-051019-102940 · Cited by 46
Cavallari, I., Morrow, D. A., Creager, M. A., Olin, J. W., Bhatt, D. L., Steg, P. G., Storey, R. F., Cohen, M. C., Scirica, B. S., Piazza, G., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.031062 · Cited by 43
Management of Venous Thromboembolisms: Part I. The Consensus for Deep Vein Thrombosis.
Wang, K.-L., Chu, P. H., Lee, C., Pai, P. Y., Lin, P.-Y., Shyu, K. G., Chang, W., Chiu, K., Huang, C.-L., Lee, C. Y., et al. (2016) · Europe PMC (PubMed Central) · doi:10.6515/acs20151228a · Cited by 49
Guided Antithrombotic Therapy: Current Status and Future Research Direction
Fuster, V., Bhatt, D. L., Califf, R. M., Michelson, A. D., Sabatine, M. S., Angiolillo, D. J., Bates, E., Cohen, D. J., Coller, B. S., Furie, B., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.105908 · Cited by 43
Bradbury, C. A., Fletcher, K., Sun, Y., Heneghan, C. J., Gardiner, C., Roalfe, A. K., Hardy, P., McCahon, D., Heritage, G., Shackleford, H., et al. (2019) · British Journal of Haematology · doi:10.1111/bjh.16275 · Cited by 44
Venous and Arterial Thrombosis: Is There a Link?
Prandoni, P. (2016) · Advances in experimental medicine and biology · doi:10.1007/5584_2016_121 · Cited by 40
Self-citationGoto, S., Hasebe, T., & Takagi, S. (2015) · Circulation Journal · doi:10.1253/circj.cj-14-1434 · Cited by 45
Chang, R., Scerbo, M. H., Schmitt, K. M., Adams, S. D., Choi, T. J., Wade, C. E., & Holcomb, J. B. (2017) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000001675 · Cited by 39
Siniscalchi, C., Quintavalla, R., Rocci, A., Riera‐Mestre, A., Trujillo‐Santos, J., Suriñach, J. M., Jara‐Palomares, L., Bikdeli, B., Moustafa, F., & Monréal, M. (2019) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2019.07.028 · Cited by 37
Extended Anticoagulation for VTE
Mai, V., Guay, C.-A., Perreault, L., Bonnet, S., Bertoletti, L., Lacasse, Y., Mainbourg, S., Lega, J., & Provencher, S. (2019) · CHEST Journal · doi:10.1016/j.chest.2019.02.402 · Cited by 38
Pulmonary Artery Thrombosis: A Diagnosis That Strives for Its Independence
Porembskaya, О. Y., Toropova, Y. G., Викторович, Т. В., Lobastov, K. V., Laberko, L. A., Кравчук, В. Н., Saiganov, S. A., & Brill, A. G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145086 · Cited by 38
Long-term clinical course of acute pulmonary embolism
den Exter, P. L., van der Hulle, T., Lankeit, M., Huisman, M. V., & Klok, F. A. (2013) · Blood Reviews · doi:10.1016/j.blre.2013.06.003 · Cited by 42
Ren, Y., Cao, S.-L., Li, Z., Luo, T., Feng, B., & Weng, X. (2021) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001305 · Cited by 39
Панченко, Е. П., Balahonova, T. V., Danilov, N. M., Komarov, A. L., Станиславовна, К. Е., Saidova, M. A., Shakhmatova, O. O., & Yavelov, I. S. (2021) · Eurasian heart journal · doi:10.38109/2225-1685-2021-1-44-77 · Cited by 39
Recommendations from the ICM-VTE: General
Delegates, T. I.-V. G. (2022) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.21.01531 · Cited by 38
Increased risk of CVD after VT is determined by common etiologic factors
Roach, R. E. J., Lijfering, W. M., Flinterman, L. E., Rosendaal, F. R., & Cannegieter, S. C. (2013) · Blood · doi:10.1182/blood-2013-01-479238 · Cited by 39
Lötsch, F., Königsbrügge, O., Posch, F., Zielinski, C. C., Pabinger, I., & Ay, C. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.09.001 · Cited by 38
Cohen, A. T., Imfeld, S., Markham, J., & Granziera, S. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.11.036 · Cited by 38
Resuming anticoagulation after hemorrhage: A practical approach
Colantino, A., Jaffer, A. K., & Brotman, D. J. (2015) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.82a.14047 · Cited by 35
New anticoagulants for treatment of venous thromboembolism
Franchini, M., & Mannucci, P. M. (2012) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2012.10.001 · Cited by 36
Role of platelets, neutrophils, and factor XII in spontaneous venous thrombosis in mice
Heestermans, M., Salloum‐Asfar, S., Salvatori, D. C. F., Laghmani, E. H., Luken, B. M., Zeerleder, S. S., Spronk, H. M. H., Korporaal, S. J. A., Wagenaar, G. T. M., Reitsma, P. H., et al. (2016) · Blood · doi:10.1182/blood-2015-10-672766 · Cited by 34
RetractedMai, V., Bertoletti, L., Cucherat, M., Mainbourg, S., Grangé, C., Provencher, S., & Lega, J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0214134 · Cited by 35
Venous thromboembolism: Predicting recurrence and the need for extended anticoagulation
Barnes, G. D., Kanthi, Y. M., & Froehlich, J. B. (2015) · Vascular Medicine · doi:10.1177/1358863x14566429 · Cited by 40
The Efficacy of Sulodexide in the Prevention of Postthrombotic Syndrome
Luzzi, R., Belcaro, G., Dugall, M., Hu, S., Arpaia, G., Ledda, A. G., IPPOLITO, E., Corsi, M., Ricci, A., Cotellese, R., et al. (2014) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029614533143 · Cited by 33
Heestermans, M., Salloum‐Asfar, S., Streef, T. J., Laghmani, E. H., Salvatori, D. C. F., Luken, B. M., Zeerleder, S. S., Spronk, H. M. H., Korporaal, S. J. A., Kirchhofer, D., et al. (2019) · Blood · doi:10.1182/blood-2018-06-853762 · Cited by 34
Akrawinthawong, K., Park, J. W., Piknova, B., Sibmooh, N., Fucharoen, S., & Schechter, A. N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092435 · Cited by 32
The association of smoking with venous thrombosis in women: A population-based, case-control study
Wiggins, K. L., McKnight, B., Psaty, B. M., Rice, K. M., Heckbert, S. R., Smith, N. L., & Blondon, M. (2013) · Thrombosis and Haemostasis · doi:10.1160/th12-10-0732 · Cited by 32
Bokshan, S. L., DeFroda, S. F., Panarello, N. M., & Owens, B. D. (2018) · Orthopaedic Journal of Sports Medicine · doi:10.1177/2325967118781328 · Cited by 33
Treatment of antiphospholipid syndrome
Radin, M., Cecchi, I., Rubini, E., Foddai, S. G., Barinotti, A., Menegatti, E., Roccatello, D., & Sciascia, S. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108597 · Cited by 35
Antiplatelet agents for the treatment of deep venous thrombosis
Flumignan, C. D. Q., Nakano, L. C. U., Baptista-Silva, J. C., & Flumignan, R. L. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012369.pub2 · Cited by 40
Hansen-Krone, I. J., Enga, K. F., Sudduth-Klinger, J., Mathiesen, E. B., Njølstad, I., Wilsgaard, T., Watkins, S. M., Brækkan, S. K., & Hansen, J. (2014) · Journal of Nutrition · doi:10.3945/jn.113.189548 · Cited by 36
Elboudwarej, O., Patel, J. K., Liou, F., Rafiei, M., Osborne, A. D., Chai, W., Kittleson, M. M., Czer, L. S. C., Stern, L. K., Esmailian, F., et al. (2015) · Clinical Transplantation · doi:10.1111/ctr.12566 · Cited by 31
Hull, C. M., Rajendran, D., & Barnes, A. F. (2015) · Wilderness and Environmental Medicine · doi:10.1016/j.wem.2015.10.010 · Cited by 31
Douketis, J. D. (2016) · Internal and Emergency Medicine · doi:10.1007/s11739-016-1553-0 · Cited by 30
Prevention of early complications following total hip replacement
Fontalis, A., Berry, D. J., Shimmin, A., Slullitel, P. A., Buttaro, M. A., Cao, L., Malchau, H., & Haddad, F. S. (2021) · SICOT-J · doi:10.1051/sicotj/2021060 · Cited by 33
Long-Term Management of Pulmonary Embolism: A Review of Consequences, Treatment, and Rehabilitation
Højen, A. A., Nielsen, P. B., Overvad, T. F., Albertsen, I. E., Klok, F. A., Rolving, N., Søgaard, M., & Ording, A. G. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11195970 · Cited by 32
Guerreiro, E. M., Kruglik, S. G., Swamy, S. K., Latysheva, N., Østerud, B., Guigner, J., Sureau, F., Bonneau, S., Kuzmin, A. N., Prasad, P. N., et al. (2024) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2024.01.004 · Cited by 31
Ngaini, Z., & Mortadza, N. A. (2018) · Natural Product Research · doi:10.1080/14786419.2018.1486310 · Cited by 32
Risk and protective factors for post-thrombotic syndrome after deep venous thrombosis
Cucuruz, B., Kopp, R., Pfister, K., Noppeney, J., Tripal, K., Korff, T., Zeman, F., Koller, M. T., & Noppeney, T. (2019) · Journal of Vascular Surgery Venous and Lymphatic Disorders · doi:10.1016/j.jvsv.2019.10.012 · Cited by 31
Christiansen, M., Grove, E. L., & Hvas, A. (2021) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0041-1726096 · Cited by 32
Extended anticoagulation after venous thromboembolism: should it be done?
Fernandes, C. J. C. D. S., Calderaro, D., Piloto, B. M., Hoette, S., Jardim, C., & Souza, R. (2019) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753466619878556 · Cited by 28
Minno, M. N. D. D., Calcaterra, I. L., Papa, A., Lupoli, R., Minno, A. D., Maniscalco, M., & Ambrosino, P. (2021) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2021.04.004 · Cited by 29
Contemporary rates of inferior vena cava filter thrombosis and risk factors
King, R. W., Wooster, M., Veeraswamy, R. K., & Genovese, E. A. (2021) · Journal of Vascular Surgery Venous and Lymphatic Disorders · doi:10.1016/j.jvsv.2021.07.016 · Cited by 30
Abd‐El‐Aziz, A. S., Benaaisha, M. R., Abdelghani, A. A., Bissessur, R., Abdel‐Rahman, L. H., Fayez, A. M., & El‐ezz, D. A. (2021) · Biomolecules · doi:10.3390/biom11111568 · Cited by 31
Incidence and risk factors of venous thromboembolism in men and women
Lind, M. M., Johansson, M., Själander, A., & Johansson, L. (2022) · Thrombosis Research · doi:10.1016/j.thromres.2022.04.014 · Cited by 28
Platelets as Central Actors in Thrombosis—Reprising an Old Role and Defining a New Character
Stevens, H., & McFadyen, J. D. (2019) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0039-1698829 · Cited by 31
Assessing recurrence risk following acute venous thromboembolism: use of algorithms
Poli, D., & Palareti, G. (2013) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e328363ed7c · Cited by 28
How Fragile Are Clinical Trial Outcomes That Support the CHEST Clinical Practice Guidelines for VTE?
Edwards, E. A., Wayant, C., Besas, J., Chronister, J., & Vassar, M. B. (2018) · CHEST Journal · doi:10.1016/j.chest.2018.01.031 · Cited by 28
Succinct Review of the New VTE Prevention and Management Guidelines
Pollak, A. W., & McBane, R. D. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.11.015 · Cited by 28
Statins, aspirin and risk of venous thromboembolic events in breast cancer patients
Shai, A., Rennert, H. S., Lavie, O., Ballan-Haj, M., Bitterman, A., Steiner, M., Keren, S., & Rennert, G. (2013) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-013-1015-8 · Cited by 28
Venous Thromboembolism in Sepsis: From Bench to Bedside
Galli, E., Maggio, E., & Pomero, F. (2022) · Biomedicines · doi:10.3390/biomedicines10071651 · Cited by 28
Recent developments in the diagnosis and treatment of pulmonary embolism
van der Hulle, T., Dronkers, C. E. A., Klok, F. A., & Huisman, M. V. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12404 · Cited by 28
Piazza, G. (2015) · Vascular Medicine · doi:10.1177/1358863x14568706 · Cited by 30
Lazo‐Langner, A., Fleet, J. L., McArthur, E., & Garg, A. X. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12675 · Cited by 28
Prandoni, P., Barbar, S., Milan, M., Vedovetto, V., & Pesavento, R. (2013) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2013.09.005 · Cited by 26
Self-citationCancer and Thrombotic Risk: The Platelet Paradigm
Lee, E. C., & Cameron, S. J. (2017) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2017.00067 · Cited by 26
Becattini, C., & Agnelli, G. (2017) · European Respiratory Journal · doi:10.1183/13993003.01732-2016 · Cited by 26
Self-citationThe 125th Anniversary of Aspirin—The Story Continues
Werz, O., Stettler, H., Theurer, C., & Seibel, J. (2024) · Pharmaceuticals · doi:10.3390/ph17040437 · Cited by 28
New Trends in Anticoagulation Therapy
SMITH, M. H. D., Wakam, G. K., Wakefield, T. W., & Obi, A. T. (2018) · Surgical Clinics of North America · doi:10.1016/j.suc.2017.11.003 · Cited by 26
Treatment of Venous Thromboembolism in Special Populations with Direct Oral Anticoagulants
Bavalia, R., Middeldorp, S., Weißer, G., & Espinola–Klein, C. (2020) · Thrombosis and Haemostasis · doi:10.1055/s-0040-1710314 · Cited by 26
Castellucci, L. A., Gal, G. L., Rodger, M. A., & Carrier, M. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12501 · Cited by 27
Risk assessment for recurrence and optimal agents for extended treatment of venous thromboembolism
Agnelli, G., & Becattini, C. (2013) · Hematology · doi:10.1182/asheducation-2013.1.471 · Cited by 27
Self-citationDevelopments in the management and treatment of pulmonary embolism
Limbrey, R., & Howard, L. (2015) · European Respiratory Review · doi:10.1183/16000617.00006614 · Cited by 28
Platelet function as a risk factor for venous thromboembolism in the Framingham Heart Study
Puurunen, M. K., Hwang, S., O'Donnell, C. J., Tofler, G. H., & Johnson, A. D. (2017) · Thrombosis Research · doi:10.1016/j.thromres.2017.01.010 · Cited by 27
Vázquez-Santiago, M., Vilalta, N., Cuevas, B., Murillo, J., Llobet, D., Macho, R., Pujol‐Moix, N., Carrasco, M., Mateo, J., Fontcuberta, J., et al. (2018) · Thrombosis Research · doi:10.1016/j.thromres.2018.07.012 · Cited by 28
Orsi, F. A., Lijfering, W. M., van der Laarse, A., Ruhaak, L. R., Rosendaal, F. R., Cannegieter, S. C., & Cobbaert, C. M. (2019) · Clinical Epidemiology · doi:10.2147/clep.s196266 · Cited by 27
Bleeding and clotting in hereditary hemorrhagic telangiectasia
Dittus, C. E., Streiff, M., & Ansell, J. (2015) · World Journal of Clinical Cases · doi:10.12998/wjcc.v3.i4.330 · Cited by 25
Statins, aspirin and risk of thromboembolic events in ovarian cancer patients
Shai, A., Rennert, H. S., Rennert, G., Sagi, S., Leviov, M., & Lavie, O. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.03.006 · Cited by 26
Thromboprophylaxis in Head and Neck Microvascular Reconstruction
Abraham, M. T., Badhey, A. K., Hu, S., Kadakia, S., Rasamny, J. K., Moscatello, A. L., & Ducic, Y. (2017) · Craniomaxillofacial Trauma & Reconstruction · doi:10.1055/s-0037-1607068 · Cited by 26
Robertson, L., Yeoh, S. E., & Ramli, A. H. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011088.pub2 · Cited by 29
Valeriani, E., Porreca, E., Weitz, J. I., Schulman, S., Candeloro, M., & Nisio, M. D. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14807 · Cited by 26
Barra, S., Paiva, L., Providencia, R. A., Fernandes, A. S., & Marques, A. L. (2013) · Clinical Cardiology · doi:10.1002/clc.22144 · Cited by 23
New oral anticoagulants for the treatment of venous thromboembolism
Agnelli, G., Becattini, C., & Franco, L. (2013) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2013.07.005 · Cited by 23
Self-citation
Metadata
- Authors
- Becattini, C., Agnelli, G., Schenone, A., Eichinger, S., Bucherini, E., Silingardi, M., Bianchi, M., Moia, M., Ageno, W., Vandelli, M. R., Grandone, E., & Prandoni, P.
- Affiliations
- University of Perugia (IT)
- Ente Ospedaliero Ospedali Galliera (IT)
- Medical University of Vienna (AT)
- Ospedale per gli Infermi (IT)
- Santa Maria Nuova Hospital (IT)
- Ospedale Valduce (IT)
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
- University of Insubria (IT)
- Casa Sollievo della Sofferenza (IT)
- University of Padua (IT)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-05-24
- Volume
- 366
- Issue
- 21
- Pages
- 1959-1967
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1975990989
- Cited by
- 620
- References
- 37
- Citations by year
- 2026: 10 · 2025: 27 · 2024: 19 · 2023: 11 · 2022: 23 · 2021: 39 · 2020: 40 · 2019: 34 · 2018: 45 · 2017: 53 · 2016: 52 · 2015: 75 · 2014: 69 · 2013: 90 · 2012: 33
- FWCI
- 57.79
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion, other-oa)
- BOA (University of Milano-Bicocca) (submittedVersion)
- IrInSubria (University of Insubria) (submittedVersion)
- Iris (University of Trento) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion, other-oa)
- Funders
- Bristol-Myers Squibb
- Pfizer
- GlaxoSmithKline
- Sanofi
- Bayer HealthCare
- Università degli Studi di Perugia
- Daiichi Sankyo Europe
- Topics
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Keywords
- aspirin, venous thromboembolism, recurrence prevention, unprovoked venous thromboembolism, major bleeding, secondary prevention, anticoagulation
- MeSH terms
- Aged, Anticoagulants, Aspirin, Double-Blind Method, Female, Follow-Up Studies, Hemorrhage, Humans, Male, Middle Aged, Platelet Aggregation Inhibitors, Pulmonary Embolism, Vitamin K, Venous Thrombosis, Venous Thromboembolism, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.